Ngene Therapeutics Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
2
Ngene Therapeutics General Information
Description
Manufacturer of gene-based stem cell therapy products designed for acute alcoholic hepatitis and various neuroinflammatory indications. The company develops optimized, safe, and homogenous stem cells by combining CRISPR/Cas9 technology with cell lines produced by the global stem cell ArrayTM.
Contact Information
Corporate Office
- MD
- United States
Corporate Office
- MD
- United States
Ngene Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ngene Therapeutics FAQs
-
Where is Ngene Therapeutics headquartered?
Ngene Therapeutics is headquartered in MD.
-
What industry is Ngene Therapeutics in?
Ngene Therapeutics’s primary industry is Biotechnology.
-
Is Ngene Therapeutics a private or public company?
Ngene Therapeutics is a Private company.
-
What is Ngene Therapeutics’s current revenue?
The current revenue for Ngene Therapeutics is .
-
When was Ngene Therapeutics acquired?
Ngene Therapeutics was acquired on 18-Dec-2020.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process